Search

everythinglearnresearchcommunity

for

Search:↓

Calancardin B may help reduce inflammation in immune cells.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

DCPA is a chronic skin condition affecting the lower limbs, mainly in men, with unclear causes and treatments that often don't work well.

Hydroxychloroquine is less effective than betamethasone oral mini pulse therapy for treating alopecia areata.

Women are more likely to have Lichen planopilaris, and treatments with cyclosporine and methotrexate are most effective but less safe than mycophenolate mofetil.

Pentoxifylline effectively improves pretibial pruritic papular dermatitis.

Neotropical porcupines can get co-infected with poxvirus and Toxoplasma gondii.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

A man developed severe skin reactions after using a treatment for hair loss.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Cyclosporine cleared a woman's resistant skin condition quickly and kept it away for over a year.

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

Upadacitinib may effectively treat resistant lichen planopilaris.

PBX1 helps hair stem cells grow and change by turning on certain cell signals and preventing cell death, which may be useful for hair regrowth treatments.

Bacopa procumbens extract may help protect the brain in Parkinson's disease.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Inflammation in psoriasis may trigger antimicrobial peptides and cell death.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

The treatment increased total hair count but wasn't significantly better than placebo.

Sodium valproate can worsen psoriasis-like skin conditions.

Dupilumab effectively reduces symptoms of prurigo nodularis and is safe for long-term use.

Anti-complement agents could effectively treat autoimmune diseases with fewer side effects.

Plaquenil can cause a severe skin reaction called AGEP, requiring prompt diagnosis and treatment.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Placenta polypeptide injection is a safe and effective treatment for sensitive skin.

Cell proteomic footprinting enhances cancer vaccine quality by ensuring correct antigen composition.